Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 15, 2026
Can you apply?
This grant is for researchers and research institutions seeking to develop and validate novel tools for studying cell-specific and circuit-specific processes in the brain. Eligible applicants include academic research institutions, hospitals, independent research institutes, nonprofits, small businesses, and other public and private organizations with the capacity to conduct NIH-funded research. Applicants must have institutional research infrastructure and support (IRB, IBC, and/or IACUC as needed) and ability to comply with federal regulations. This program specifically does not support clinical trials. Research projects should focus on innovative methodological development and validation of tools, technologies, or approaches that enable investigation of specific brain cells or circuits, with relevance to understanding brain function in normal and disease states.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new genetic and non-genetic tools for delivering genes, proteins and chemicals to cells of interest or approaches that are expected to target specific cell types and/or circuits in the nervous system with greater precision and sensitivity than currently established methods are encouraged. Tools that can be used in a number of species/model organisms rather than those restricted to a single species are highly desired. Applications that provide approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- SF-424 (R&R) form and project narrative (typically 12-15 pages for R01)
- Detailed budget and budget justification
- Biographical sketch for PI and key personnel (NIH format, 2 pages each)
- Letters of support from collaborators and institutional resources
- Preliminary data demonstrating feasibility and proof-of-concept
- Detailed research methods and validation strategy
- Institutional research capabilities documentation (IRB/IACUC/IBC assurance letters if needed)
- Resource sharing plan for data and tools developed
- Conflict of interest disclosures
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.273 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$125,900,663
-
$34,675,742
-
$34,469,501
-
$33,261,336
-
$32,897,567
-
$31,652,514
-
$30,394,602
-
$29,223,384
-
$29,195,978
-
$29,168,993
Top States by Funding
- CA 15 awards $242.3M
- NY 3 awards $162.6M
- OR 7 awards $96.3M
- NC 4 awards $67.1M
- IN 3 awards $57.4M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.273). How funding has trended year over year.
| 2024 | $430,377,419 | |
| 2025 | $429,906,735 | |
| 2026 est. | $12,401,560 |
FAQ
Who can apply for this grant?
Academic research institutions, hospitals, nonprofit organizations, small businesses, and other public/private organizations capable of conducting NIH-funded research. Principal investigators must typically hold a doctoral degree and an appointment at an eligible institution. Foreign institutions may be eligible under certain conditions.
What are the funding and timeline details?
This is an R01 grant mechanism. Typical R01 awards range from $250,000 to $500,000 annually depending on the field and project scope. Projects are typically funded for 4-5 years. The deadline for this cycle is February 8, 2027, with applications opening November 15, 2024.
What activities and research are supported?
Grants support development, refinement, and validation of novel tools, techniques, or technologies for probing cell-specific or circuit-specific brain processes. This includes methodological research, tool optimization, and proof-of-concept studies. Clinical trials are not supported under this particular R01 announcement.
How competitive is this grant?
BRAIN Initiative grants are highly competitive, with success rates typically ranging from 15-25% depending on the specific program. Reviewers prioritize scientific innovation, technical rigor, feasibility, and clear potential for advancing neuroscience research methods and understanding.
What is the typical budget range?
R01 grants typically request between $250,000 and $500,000 per year in direct costs, though budgets can vary. Applicants should review current NIH policy for any caps or modular budgeting requirements and justify their specific budget based on project scope and complexity.
💡 Tips for applicants
- Emphasize the novelty and innovation of your tools or approaches. Reviewers want to see how your development advances beyond existing methods and why existing tools are insufficient. Include preliminary data demonstrating proof-of-concept and technical feasibility.
- Clearly define the specific brain cells, circuits, or processes your tool will target. Use precise language about what makes your approach "cell-specific" or "circuit-specific" and provide a compelling rationale for studying these particular biological systems.
- Plan a rigorous validation strategy with realistic milestones and measurable success criteria. Include independent validation studies, comparison to existing methods, and plans to make your tool accessible to the broader neuroscience community.
- Address the translational potential and broader impact. Even though clinical trials aren't supported, explain how your tool will benefit neuroscience research and potentially inform future clinical or therapeutic applications.
- Coordinate with your institution's grants office early. Ensure all required resources (equipment, core facilities, collaborators) are secured, institutional support is documented, and biosafety/animal care approvals are in place before submission.
⚠️ Common mistakes
Applications often fail when the proposed tool development is too incremental or lacks sufficient novelty—reviewers want transformative methodologies, not minor refinements of existing approaches. Applicants frequently underestimate the effort required for rigorous validation and present insufficient preliminary data, making the feasibility questionable. Additionally, some proposals blur the boundary into clinical application or clinical trial territory, which violates the "Clinical Trial Not Allowed" restriction; maintain clear focus on methodological research and tool development rather than human subject studies or therapeutic interventions.
Similar grants
- OPEN BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research — National Institutes of Health
- OPEN BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) — National Institutes of Health
- OPEN BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 – Clinical Trial Not Allowed) — National Institutes of Health